QiJun Zhang

QiJun Zhang


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Pan African Medical Journal
Verified
Journal Article
Open access
QZQiJun Zhang
QiJun Zhang
HMHao-Zhen Miao
Hao-Zhen Miao
LTLei Tao
Lei Tao
BSBing-Jie Song
Bing-Jie Song
YCYong Cao
Yong Cao
In this case report, we will discuss a 74-year-old female who presented with a chief complaint of abdominal pain, bloating, anorexia, and nausea for four days which preceded after catheter ablation and anhydrous ethanol infusion vein of Marshall (VOM) one month prior. She was admitted and treated as a general patient in the general ward. After hospital admission, a pericardiocentesis was guided by B-scan ultrasonography, resulting in the extraction of 20ml of pericardial effusion, followed by catheterization for drainage. The key takeaway in this report is that anhydrous ethanol infusion VOM may not always be without risks. Hence, during the procedure, it is imperative to carefully administer the appropriate volume of anhydrous ethanol into the VOM to prevent vessel damage and associated complications.

6 January 2025 in Renal Failure
Verified
Journal Article
Open access
DCDebin Chen
Debin Chen
YYYongju Ye
Yongju Ye
YLYining Li
Yining Li
EXErxu Xue
Erxu Xue
QZQiJun Zhang
QiJun Zhang
JZJianhui Zhao
Jianhui Zhao
Chronic kidney disease (CKD) is a prevalent chronic, non-communicable disease. The long-term health effects of dietary live microbes, primarily probiotics, on CKD patients remain insufficiently understood. This study aims to investigate the association between dietary intake of live microbes and long-term health outcomes among individuals with CKD. Utilizing the National Health and Nutrition Examination Survey (NHANES) database, Cox regression analysis assessed the association between medium and high categories dietary live microbe intake and health outcomes (all-cause, cardiovascular disease [CVD], and cancer-related mortality) in CKD patients. A total of 3,646 CKD patients were enrolled. During the follow-up period, 1,593 all-cause mortality events were recorded, including 478 CVD deaths and 268 cancer deaths. In the fully adjusted model, compared to CKD patients in the lowest quartile (quartile 1) of live microbes intake, those in quartiles 3 and 4 exhibited a 20% and 26% reduced risk of all-cause mortality, with hazard ratios (HR) of 0.80 (95% confidence interval, CI: 0.69, 0.94) and 0.74 (95% CI: 0.62, 0.90), respectively. Additionally, compared to those with low live microbe intake (quartile 1), higher live microbe intake in quartile 4 was associated with a 37% reduction in the risk of CVD mortality for CKD patients, with an HR of 0.63 (95% CI: 0.45, 0.88). Consistent results were observed in subgroup and sensitivity analyses. A significant negative association was observed between live microbe intake and the risk of all-cause mortality as well as CVD mortality in the CKD population, with a p-value for trend < 0.05. Our study indicated that high dietary live microbe intake could mitigate the risk of all-cause and CVD mortality in CKD patients. These findings support the inclusion of live microbes in dietary recommendations, highlighting their significant roles in CKD.

1 January 2024 in Pan African Medical Journal
Verified
Journal Article
Open access
QZQiJun Zhang
QiJun Zhang
FSFeiqin Shi
Feiqin Shi
BSBingjie Song
Bingjie Song
YBYingchun Bao
Yingchun Bao
YCYong Cao
Yong Cao
This study Assessed the safety of Antiarrhythmic Drug (AAD) administration in a patient experiencing sinus bradycardia following radiofrequency ablation for Atrial Fibrillation (AF), followed by cardiac ganglion ablation. Post-AF radiofrequency ablation, the employment of AADs is a prevalent clinical practice; however, these drugs may exacerbate bradycardia, leading to increased patient discomfort and treatment complexity. The decision to employ AADs in patients with sinus bradycardia post-AF ablation poses a significant clinical challenge. This investigation aimed to ascertain the safety of AADs in such patients. The study encompassed a single case, wherein a patient with pre- and post-procedure sinus bradycardia was treated with AADs following AF radiofrequency ablation and cardiac ganglion ablation, with a subsequent safety assessment. The findings indicate that AADs can be safely administered to patients with sinus bradycardia after these procedures, offering valuable insights for clinical decision-making. This case report underscores the intricacies of post-AF ablation management in patients with sinus bradycardia and advocates for personalized therapeutic strategies. The results enhance the clinical knowledge regarding the safety of AADs in this patient subset and may guide future treatment protocols. Nonetheless, the study´s conclusions are drawn from a single case, and further research with larger cohorts is essential to substantiate these findings and elucidate the long-term safety and efficacy of this therapeutic approach.

10 February 2026 in American Journal of Preventive Cardiology
Verified
Journal Article
Open access
XZXuecui Zhang
Xuecui Zhang
DCDebin Chen
Debin Chen
LWLiangwei Wu
Liangwei Wu
YZYizhou Zhuang
Yizhou Zhuang
JYJiakang Yang
Jiakang Yang
JZJianhui Zhao
Jianhui Zhao
Dietary niacin, an essential nutrient, protects against metabolic diseases; however, its association with Cardiovascular-Kidney-Metabolic (CKM) syndrome and related mortality remains poorly understood. We examined the associations between dietary niacin intake and the prevalence of advanced CKM syndrome using logistic regression models, as well as the associations between dietary niacin intake and mortality (all-cause, cardiovascular, and cancer) across CKM stages using Cox proportional hazards models, based on data from the National Health and Nutrition Examination Survey. Non-linear relationships were examined using restricted cubic spline (RCS) analyses. Among the 14,282 participants, 14.3% (2,042/14,282) were identified as having advanced-stage CKM syndrome. Higher dietary niacin intake was inversely associated with the prevalence of advanced-stage CKM syndrome (odds ratio [OR] = 0.72, 95% CI: 0.62-0.85). Stronger inverse associations were observed among participants aged over 40 years, those with higher physical activity levels, and those without hyperlipidemia. In patients with CKM stages 0-2, higher niacin intake was inversely associated with the risks of all-cause mortality (hazard ratio [HR] 0.75, 95% CI: 0.61-0.91), cardiovascular mortality (HR 0.53, 95% CI: 0.29-0.94), and cancer mortality (HR 0.70, 95% CI: 0.49-0.93). In patients with CKM stages 3-4, higher niacin intake was negatively associated with the risks of all-cause mortality (HR 0.82, 95% CI: 0.67-0.97) and cancer mortality (HR 0.53, 95% CI: 0.29-0.95). RCS analysis revealed a negative linear relationship of dietary niacin with advanced CKM syndrome and non-linear associations with all-cause, cardiovascular, and cancer mortality among patients in CKM stages 3-4. Dietary niacin intake may be associated with a lower prevalence of advanced-stage CKM syndrome and reduced mortality across all CKM stages, suggesting its potential role in dietary interventions for CKM prevention and management.

Verified
Journal Article
Open access
PDF file
BSBingjie Song
Bingjie Song
QZQiJun Zhang
QiJun Zhang
LTLei Tao
Lei Tao
YBYingChun Bao
YingChun Bao
CLChen Luo
Chen Luo
Background: As a rare disease, cardiac amyloidosis (CA) has seen a deepening of epidemiological understanding, driven by advances in imaging and genetic testing, alongside drug development. However, the identification of suspected patients in the early stages remains inadequate. Case Presentation: Our 64-year-old patient carrying the rare transthyretin variant p.Gly67Val (legacy nomenclature Gly47Val) originally presented with lower limb numbness, resulting in prolonged follow-up at neurology outpatient clinics. Subsequently, unexplained hypotension led to hospital admission. The atypical early symptoms and inaccessibility of relevant tests delayed diagnosis and treatment. Discussion: As illustrated by this case, patients with CA referral to a specialist for further diagnosis and treatment typically occur when heart failure and conduction abnormalities have developed, a stage at which treatment outcomes are substantially limited. The p.Gly67Val variant ATTR-CA has been reported in about 20 carriers worldwide, with phenotypes ranging from neuropathy-dominant to cardiac-dominant disease; this case extends the emerging mixed phenotype of this spectrum. Conclusions: This case highlights the importance of recognizing extracardiac manifestations to reduce diagnostic delay in hereditary transthyretin cardiac amyloidosis.

1 January 2024 in Pan African Medical Journal
Verified
Journal Article
Open access
QZQiJun Zhang
QiJun Zhang
FSFeiqin Shi
Feiqin Shi
BSBingJie Song
BingJie Song
YBYingChun Bao
YingChun Bao
YCYong Cao
Yong Cao
This case presents a patient who experienced hypoxia and hypotension following the infusion of industrial-grade anhydrous ethanol into the vein of Marshall (VOM) during atrial fibrillation radiofrequency ablation. The hypotension lasted for at least three days, requiring dopamine support, while hypoxia persisted for over a week. The prolonged nature of these symptoms posed a diagnostic challenge. A thorough review of the patient´s medications and an extensive literature search suggested that the use of industrial-grade anhydrous ethanol may have been the cause. This case highlights the potential risks associated with the use of non-medical grade substances in clinical procedures, emphasizing the importance of careful material selection to avoid severe complications.